CAS: 1803274-65-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | BAY-1436032 REF: IN-DA00AMHDCAS: 1803274-65-8 | 99% | To inquire | Tue 10 Dec 24 |
 | BAY-1436032 REF: TM-TQ0042CAS: 1803274-65-8 | 99.38% - 99.65% | To inquire | Mon 16 Dec 24 |
 | BAY-1436032 REF: 3D-DXC27465CAS: 1803274-65-8 | Min. 95% | To inquire | Tue 21 Jan 25 |
Ref: IN-DA00AMHD
| 1mg | 144.00 € | ||
| 5mg | 469.00 € | ||
| 10mg | 496.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
BAY-1436032
CAS:1803274-65-8
BAY-1436032 is a novel, selective and orally available inhibitor of pan-mutant isocitrate dehydrogenase 1 (IDH1).
Formula:
C26H30F3N3O3
Purity:
99.38% - 99.65%
Color and Shape:
Solid
Molecular weight:
489.53
Ref: TM-TQ0042
| 1mg | 37.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 118.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 1mL*10mM (DMSO) | 84.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
BAY-1436032
CAS:1803274-65-8
BAY-1436032 is a novel small molecule inhibitor of CXCR4. It has been shown to be …
Formula:
C26H30F3N3O3
Purity:
Min. 95%
Molecular weight:
489.53 g/mol
Ref: 3D-DXC27465
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
